Auhtors: Debebe A, Medina V, Chen CY, Mahajan IM, Jia C, Fu D, et al.
PMID: 34591416 PMCID: PMC8958883 DOI: 10.20892/j.issn.2095-3941.2021.0306
Abstract
The Wnt/β-catenin signaling pathway regulates many aspects of tumor biology, and many studies have focused on the role of this signaling pathway in tumor cells. However, it is now clear that tumor development and metastasis depend on the two-way interaction between cancer cells and their environment, thereby forming a tumor microenvironment (TME). In this review, we discuss how Wnt/β-catenin signaling regulates cross-interactions among different components of the TME, including immune cells, stem cells, tumor vasculature, and noncellular components of the TME in hepatocellular carcinoma. We also investigate their preclinical and clinical insights for primary liver cancer intervention, and explore the significance of using Wnt/β-catenin mutations as a biomarker to predict resistance in immunotherapy.
Keywords: HCC; Wnt/β-catenin signaling; immunotherapy; tumor microenvironment.
Source: https://pubmed.ncbi.nlm.nih.gov/34591416/
Archive: https://archive.is/3nnl3
